PRESS RELEASE published on 04/30/2024 at 08:00, 1 year 7 months ago First participation of OSMOSUN at IFAT OSMOSUN® to showcase sustainable desalination solutions at IFAT 2024 in Munich, illustrating commitment to innovative water resource management. Unique solar-powered units with high energy efficiency. Recent presence at major water management events enhancing OSMOSUN®'s reputation and partnerships IFAT 2024 OSMOSUN® Sustainable Desalination Solutions Water Resource Management Solar-powered Units
BRIEF published on 04/23/2024 at 18:35, 1 year 7 months ago 2023 annual results for OSMOSUN: growth investments despite project delays Strategic Partnerships 2023 Financial Results Financial Outlook OSMOSUN Growing Investments
PRESS RELEASE published on 04/23/2024 at 18:30, 1 year 7 months ago 2023 annual results OSMOSUN® reports 2023 results influenced by growth investments & IPO fundraising. Financial guidance shifted to 2026-2028 due to longer decision-making cycles on major projects Financial Guidance 2023 Results Growth Investments OSMOSUN IPO Fundraising
Published on 12/05/2025 at 02:35, 3 hours 23 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 58 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 53 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 58 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 28 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 7 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 33 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 43 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 48 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 58 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 13 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 14 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 57 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
